Stock CYTK CYTOKINETICS, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
65.27 USD +1.45% Intraday chart for Cytokinetics, Incorporated -0.11% -21.82%
04-26 Cytokinetics Appoints Sung Lee as CFO MT
04-26 Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CYTK Stock
  4. Revisions Cytokinetics, Incorporated